The Latest in Critical Care, 3/25/24 (Issue #35)
Machine learning to guide oxygen targets in ventilated patients; Extracorporeal carbon dioxide removal in COPD exacerbations (VENT-AVOID trial)
Machine learning to individualize oxygenation targets during mechanical ventilation
·
Multiple randomized trials in heterogeneous patients requiring mechanical ventilation have not shown any benefit from any particular oxygenation target (higher vs. lower). But what if those trials’ negative results hid a more complex reality, in which patients
Extracorporeal CO2 removal for COPD exacerbations (VENT-AVOID trial)
·
Extracorporeal membrane oxygenation (ECMO) is a sometimes life-saving technology for acute respiratory or cardiac failure. ECMO remains primarily a rescue or bridging therapy, but as the technology has evolved, potential new applications continue to be tested.